Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TRDATRDA
Showing 8 of 19 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ENTRADA THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 717,430 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $5.3M as of 2026-Q2. The position was increased (+7.5% shares). TRDA represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$5.3M

Current Shares

717,430

Total Value Change

-$3.9M

Total Shares Change

+140,979

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
717,430
+7.5%
$5.3M0.0%$7.36
29
2026-Q1
Increased
667,347
+4.3%
$8.4M0.0%$11.85
29
2025-Q4
Decreased
639,947
-0.8%
$6.6M0.0%$10.09
0
2025-Q3
Increased
645,119
+2.1%
$3.7M0.0%$5.84
27
2025-Q2
Increased
631,554
+7.2%
$4.2M0.0%$6.91
29
2025-Q1
Increased
589,075
+2.6%
$5.3M0.0%$9.56
28
2024-Q4
Decreased
573,891
-0.4%
$9.9M0.0%$17.37
0
2024-Q3
Increased
576,451
+8.8%
$9.2M0.0%$16.45
30

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used